# Acute Hydroxychloroquine Overdose With Severe and Prolonged Cardiotoxicity

**Authors:** William Richardson, Dan Fisher, Stanley Hassinger, Daniel Culy, Anna Zmuda

PMC · DOI: 10.7759/cureus.88512 · Cureus · 2025-07-22

## TL;DR

A woman survived a severe hydroxychloroquine overdose with aggressive emergency treatment, highlighting the drug's potential cardiotoxicity.

## Contribution

This case report adds to the limited literature on hydroxychloroquine overdose management and its severe cardiac effects.

## Key findings

- A 49-year-old woman survived a 24-gram hydroxychloroquine overdose with intensive treatment.
- The patient experienced hypotension, torsades de pointes, and hypokalemia requiring multiple interventions.
- Despite severe toxicity, the patient was discharged neurologically intact after hospitalization.

## Abstract

We present a case of an overdose of hydroxychloroquine with severe toxicity and describe the hospital management of the patient. The management of large ingestions can provide significant challenges for the emergency medicine physician, as these patients can present in extremis. A 49-year-old woman presented to the emergency department (ED) two hours following a reported ingestion of 24 grams of hydroxychloroquine in a suicide attempt. The patient developed hypotension, ventricular arrhythmias including torsades de pointes, and profound hypokalemia. She was managed with intravenous fluid resuscitation, mechanical ventilation, vasopressors, electrolyte replacement, high-dose intravenous diazepam, sodium bicarbonate, and lidocaine infusions. The patient was ultimately able to be discharged home neurologically intact. Reported hydroxychloroquine overdoses are relatively infrequent. Understanding the toxicity and management of hydroxychloroquine overdoses is particularly important now, as the prescription rate of hydroxychloroquine increased during the COVID-19 pandemic and has remained high despite the failure of studies to demonstrate a reduction in morbidity and mortality when used for the treatment of COVID-19.

## Linked entities

- **Chemicals:** hydroxychloroquine (PubChem CID 3652), sodium bicarbonate (PubChem CID 516892), lidocaine (PubChem CID 3676), diazepam (PubChem CID 3016)
- **Diseases:** torsades de pointes (MONDO:0005478), hypotension (MONDO:0005468), hypokalemia (MONDO:0003019)

## Full-text entities

- **Diseases:** Cardiotoxicity (MESH:D066126), toxicity (MESH:D064420), ventricular arrhythmias (MESH:D001145), torsades de pointes (MESH:D016171), Overdose (MESH:D062787), COVID-19 (MESH:D000086382), hypokalemia (MESH:D007008), hypotension (MESH:D007022)
- **Chemicals:** diazepam (MESH:D003975), lidocaine (MESH:D008012), sodium bicarbonate (MESH:D017693), Hydroxychloroquine (MESH:D006886)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12282492/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12282492/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12282492/full.md

---
Source: https://tomesphere.com/paper/PMC12282492